NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1041220109

Registered date:25/12/2022

Inhibitory effect of gas anesthetics on neurophysiological monitoring in young children

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedSpinal cord diseases
Date of first enrollment25/12/2022
Target sample size20
Countries of recruitment
Study typeInterventional
Intervention(s)At our center, for pediatric spinal surgery with intraoperative neuromonitoring as a routine practice, the standard anesthetic regimen is propofol (4-10 mg/kg/h) + remifentanil (0.2-1.0 mcg/kg/min) + sevoflurane [expiratory concentration 0.3-0.5 minimum alveolar concentration (MAC)]/desflurane (0.3-0.5 MAC) after a slow induction with sevoflurane. After intubation, the patient is placed in the supine position and a neuromonitoring device is attached to measure the control current. The following research methods were employed to avoid exceeding the scope of this normal clinical practice. For general anesthesia induction, either slow induction with sevoflurane or rapid induction with propofol is performed based on the presence of a preoperatively placed peripheral venous route (standard general anesthesia). Here, anesthesia induction is performed with 5-8% sevoflurane, 2-3 mg/kg propofol, and 2 mcg/kg fentanyl under 40% nitrous oxide, and intubation is performed (the usual method of anesthesia induction at our center). At the end of airway clearance, propofol (4 mg/kg/h) and remifentanil (0.5 mcg/kg/min) (hereafter TIVA) are started as the base general anesthesia (this is the same as the usual anesthesia flow). In the desflurane addition group (group D), sevoflurane administration is discontinued and desflurane is started to achieve the target concentration. Once the concentration of anesthetics in the expired gas has stabilized, neuromonitoring potentials (motor evoked potentials (MEPs), somatosensory evoked potentials (SEPs), bulbocavernous reflexes (BCRs)) are assessed. (BCR) potential diagrams are recorded and stored. Gas anesthetics (sevoflurane and desflurane) are then discontinued and a washout of at least 20 minutes is performed. The end-expiratory sevoflurane concentration is monitored to ensure that it is less than measurable (3 L/min minute ventilation volume). A second round of monitoring is then performed on the same patient under TIVA anesthesia alone, and each (MEP, SEP, BCR) potential diagram is recorded and stored. All of these recordings will be done as part of the normal surgical process of recording potential control prior to the start of surgery, and given the time required to prepare for the start of surgery, a significant delay in the start of surgery is not anticipated due to the study. About the Interventions The two interventions in this study are as follows. (i) TIVA [propofol (4 mg/kg/h) and remifentanil (0.5 mcg/kg/min) Sevoflurane (age-adjusted MAC=0.2) will be added (ii) TIVA [propofol (4 mg/kg/h) and remifentanil (0.5 mcg/kg/min) Desflurane (age-adjusted MAC = 0.2) will be added After the usual (above) induction of general anesthesia, confirm that the exhaled concentration of the inhaled anesthetic has reached 0% under TIVA anesthesia, then perform neuromonitoring under TIVA anesthesia (X minutes after the start of administration) and record and store potentials. Sevoflurane or desflurane will then be administered, and after the exhaled concentration stabilizes at an age-adjusted MAC=0.2, neuromonitoring will be performed again in the same patients, and potentials will be recorded and stored. Twenty patients will be pre-randomized by computer into two groups (sevoflurane and desflurane groups).

Outcome(s)

Primary OutcomePercentage of reducing the amplitude in the neuromonitoring results on the patient's upper limbs.
Secondary OutcomeNone

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximum< 3age old
GenderBoth
Include criteriaPatients younger than 2 years old who undergoing elective spinal surgery Initial surgery case
Exclude criteriaPatients with preoperative immobility of lower limbs Patients who are contraindicated to use inhalational anesthetics or propofol Patients or patient's families do not agree with study participation Patients who show unstable hemodynamics Patients who show any signs of insufficient anesthesia

Related Information

Contact

Public contact
Name TAIKI KOJIMA
Address 7-426 Morioka-cho Obu city Aichi Aichi Japan 474-8710
Telephone +81-562-43-0500
E-mail fumio.bb@gmail.com
Affiliation Aichi Children Health and Medical Center
Scientific contact
Name Taiki Fumio Kojima
Address 7-426 Morioka-cho Obu city Aichi Aichi Japan 4748710
Telephone +81-562430500
E-mail daiki_kojima@sk00106.achmc.pref.aichi.jp
Affiliation Aichi Children Health and Medical Center